LMATLEMAITRE VASCULAR, INC.Mid cap · $2.29B · FY ending 2025-12-31
$100.29-2.38% · 2026-07-13 · EOD
55/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality87
narrow moat · ROIC 14%Value50
P/E 39.8 · 55% of 12-mo rangeMomentum63
golden · price above 200-daySmart Money18
selling · 0 funds · 0P/4S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+9.3%
6-mo excess Trailing performance1M +8.6%
3M -12.5%
6M +17.9%
YTD +25.1%
1Y +17.0%
P/E vs its last 12 months (our price history): 31.7 low → 46.6 high
Current price sits at the 55th percentile of that window — mid-range. We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Narrow moat — ROIC 14%
Piotroski F7/9
fundamental strength Altman ZSafe
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 23%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio31.4%
comfortable Shareholder yield0.9%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net selling0P / 4S insiders · 0 funds hold · 0 Congress buys
Recent insidersJasinski Lawrence J · DirectorSELL$433,730
Ross Bridget A · DirectorSELL$560,366
Kamke Trent G · Senior V. P., OperationsSELL$313,287
LeMaitre George W · Chairman and CEOSELL$5.0M
Bhealth · 81/100
Self-fundingSelf-funding — profitable · generates cash
- ●One-sided insider selling 4 insider sales and no open-market buys in the recent window.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.